Heterocyclic compounds and methods of their use
AssigneeNovartis AG
InventorsThomas David McCarthy, Alan Naylor
Life of this patent
Estimating the term…
Loading patent…
AssigneeNovartis AG
InventorsThomas David McCarthy, Alan Naylor
Estimating the term…
The present invention relates to heterocyclic compounds useful for antagonizing angiotensin II Type 2 (AT2) receptor. More particularly the invention relates to pyrrolidine and azetidine compounds, compositions containing them and their use in methods of treating or preventing disorders or diseases associated with AT2 receptor function including neuropathic pain, inflammatory pain, conditions associated with neuronal hypersensitivity, impaired nerve conduction velocity, cell proliferation disorders, disorders associated with an imbalance between bone resorption and bone formation and disorders associated with aberrant nerve regeneration.
A compound of formula (I):
A compound of formula (I):
Dependencies are inferred from the claim text.